TAIWAN · TWSE / TPEx
InnoPharmax
因華 · 4172 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$9.941 month -6.7% · 1 year -52.1%
Directors and supervisors hold23,772,23619.9% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold22,344,23618.7% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 健喬信元醫藥生技股份有限公司 | Chairman · Director · Major shareholder (10%+) | 12,264,773 | 22,344,236 | 18.69% | — | — |
| 林智暉 | Chairman (corporate representative) | — | 494,103 | 0.41% | — | — |
| 廖尤里 | Director (corporate representative) | — | 207,095 | 0.17% | — | — |
| 鍾威廉 | Director | — | 0 | — | — | — |
| 郝為華 | Director · President | 1,422,741 | 1,427,000 | 1.19% | — | — |
| 中加顧問股份有限公司 | Director | 1,000 | 1,000 | 0.00% | — | — |
| 李啟睿 | Director (corporate representative) | — | 0 | — | — | — |
| 郭漢彬 | Director | — | 0 | — | — | — |
| 方力行 | Independent director | — | 0 | — | — | — |
| 曾雪如 | Independent director | — | 0 | — | — | — |
| 林谷同 | Independent director | — | 0 | — | — | — |
| 陳威霖 | Manager | — | 0 | — | — | — |
| 施宇耿 | Chief financial officer · Chief accountant · Other | — | 0 | — | — | — |